Found 29 matching trials
Absolute Bioavailability of Reslizumab in Healthy Subjects PHASE1 The primary objective of this study is to assess the absolute bioavailabili...
Show More Location
Teva Investigational Site 10567
Learn More & Join Trial
A Retrospective Chart Review to Investigate Clinical Remission in Patients With Severe Asthma Treated With Biologics in the United Kingdom National Health Service N/A Asthma is a common lung condition that causes occasional breathing difficul...
Show More Learn More & Join Trial
Reslizumab in the Treatment of Eosinophilic Granulomatosis With Polyangiitis (EGPA) Study PHASE2 Reslizumab is a type of medicine called a monoclonal antibody that is made ...
Show More Location
National Jewish Health
Learn More & Join Trial
Study to Evaluate the Efficacy and Safety of Reslizumab Treatment in Patients With Moderate to Severe Asthma PHASE3 The primary objective of the study is to characterize the efficacy of resli...
Show More Location
Investigational Site 861
Learn More & Join Trial
Reslizumab to Prevent Post-treatment Eosinophilia in Loiasis PHASE2 Diethylcarbamazine citrate (DEC) treatment of Loa loa infection is complica...
Show More Location
National Institutes of Health Clinical Center, 9000 Rockville Pike
Learn More & Join Trial
Expression of TSLP Isoforms in Asthma N/A Asthma is a heterogeneous disease characterized by chronic airway inflammat...
Show More Location
Department of Internal Medicine, Pulmonary Diseases and Allergy, Medical University of Warsaw, Warsaw, Poland,
Learn More & Join Trial
Open-Label Extension Study of Reslizumab in Pediatric Subjects With Eosinophilic Esophagitis PHASE3 This study is an open-label study where all subjects will receive active dr...
Show More Location
The Children's Hospital of Alabama
Learn More & Join Trial
Pharmacodynamic Biomarkers to Support Biosimilar Development: Interleukin-5 Antagonists PHASE1 This study is designed to assess pharmacokinetics and pharmacodynamics of m...
Show More Location
Spaulding Clinical Research
Learn More & Join Trial
Dupilumab as Add-On Therapy for Hypereosinophilic Syndrome With Partial Clinical Response to Eosinophil-Depleting Biologic Agents PHASE2 Background:
Hypereosinophilic syndrome (HES) is a blood disorder that caus...
Show More Location
National Institutes of Health Clinical Center
Learn More & Join Trial
Study of Chronic Rhinosinusitis Symptoms in Asthma Patients Undergoing Treatment With Reslizumab N/A The primary objective of this research is to monitor chronic rhinosinusitis...
Show More Location
University of Rochester Department of Otolaryngology Head and Neck Surgery
Learn More & Join Trial